基石药业-B（HK2616）
总股本构成
| 公告日期 |
2026-01-07 |
2025-10-08 |
2025-09-04 |
2025-08-06 |
2025-07-16 |
2025-07-07 |
2025-06-05 |
2025-04-10 |
2025-02-06 |
2024-10-07 |
2024-09-05 |
2024-04-05 |
2024-01-05 |
2023-12-06 |
2023-11-06 |
2023-10-05 |
2023-09-06 |
2023-08-04 |
2023-06-06 |
2023-05-05 |
2023-02-15 |
2023-02-06 |
2023-01-06 |
2022-12-06 |
2022-11-04 |
2022-10-07 |
2022-09-06 |
2022-08-03 |
2022-07-06 |
2022-04-06 |
2022-02-08 |
2022-01-06 |
2021-12-06 |
2021-11-03 |
2021-10-07 |
2021-09-06 |
2021-08-05 |
2021-07-05 |
2021-06-03 |
| 总股本 |
1475.98 |
1475.98 |
1467.16 |
1464.77 |
1464.72 |
1364.50 |
1364.40 |
1364.38 |
1284.38 |
1284.24 |
1284.21 |
1284.19 |
1284.16 |
1284.14 |
1284.12 |
1284.11 |
1284.07 |
1284.03 |
1283.89 |
1283.87 |
1283.84 |
1199.04 |
1198.74 |
1198.20 |
1193.47 |
1191.21 |
1188.33 |
1188.32 |
1188.31 |
1188.24 |
1188.20 |
1187.12 |
1185.59 |
1185.52 |
1185.46 |
1183.85 |
1183.61 |
1183.22 |
1182.11 |
| 普通股 |
1475.98
|
1475.98
|
1467.16
|
1464.77
|
1464.72 |
1364.50
|
1364.40
|
1364.38 |
1284.38
|
1284.24
|
1284.21
|
1284.19
|
1284.16
|
1284.14
|
1284.12
|
1284.11
|
1284.07
|
1284.03
|
1283.89
|
1283.87
|
1283.84 |
1199.04
|
1198.74
|
1198.20
|
1193.47
|
1191.21
|
1188.33
|
1188.32
|
1188.31
|
1188.24
|
1188.20
|
1187.12
|
1185.59
|
1185.52
|
1185.46
|
1183.85
|
1183.61
|
1183.22
|
1182.11
|
| 优先股 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 变动日期 |
2025-12-31 |
2025-09-30 |
2025-08-31 |
2025-07-31 |
2025-07-16 |
2025-06-30 |
2025-05-31 |
2025-04-10 |
2025-01-31 |
2024-09-30 |
2024-08-31 |
2024-03-31 |
2023-12-31 |
2023-11-30 |
2023-10-31 |
2023-09-30 |
2023-08-31 |
2023-07-31 |
2023-05-31 |
2023-04-30 |
2023-02-15 |
2023-01-31 |
2022-12-31 |
2022-11-30 |
2022-10-31 |
2022-09-30 |
2022-08-31 |
2022-07-31 |
2022-06-30 |
2022-03-31 |
2022-01-31 |
2021-12-31 |
2021-11-30 |
2021-10-31 |
2021-09-30 |
2021-08-31 |
2021-07-31 |
2021-06-30 |
2021-05-31 |
中商官网
研究报告
